Literature DB >> 15304226

Commitment to splice site pairing coincides with A complex formation.

Sharlene R Lim1, Klemens J Hertel.   

Abstract

Differential recognition of exons by the spliceosome regulates gene expression and exponentially increases the complexity of metazoan proteomes. After definition of the exons, the spliceosome is activated by a series of sequential structural rearrangements. Formation of the first ATP-independent spliceosomal complex commits the pre-mRNA to the general splicing pathway. However, the time at which a commitment to a specific splice site choice and pairing is made is unknown. Here, we demonstrate that alternative splicing patterns are irreversibly chosen at a kinetic step different from the ATP-independent commitment to splicing. Splice sites become committed at the first ATP-dependent spliceosomal complex when rearrangements lock U2 snRNP onto the pre-mRNA. Thus, commitment to the splicing pathway and commitment to splice site pairing are separate steps during spliceosomal assembly, and ATP hydrolysis drives the irreversible juxtaposition of exons within the spliceosome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304226     DOI: 10.1016/j.molcel.2004.06.025

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  43 in total

1.  First come, first served revisited: factors affecting the same alternative splicing event have different effects on the relative rates of intron removal.

Authors:  Manuel de la Mata; Celina Lafaille; Alberto R Kornblihtt
Journal:  RNA       Date:  2010-03-31       Impact factor: 4.942

2.  Retention of spliceosomal components along ligated exons ensures efficient removal of multiple introns.

Authors:  Tara L Crabb; Bianca J Lam; Klemens J Hertel
Journal:  RNA       Date:  2010-07-07       Impact factor: 4.942

3.  Characterization of a U2AF-independent commitment complex (E') in the mammalian spliceosome assembly pathway.

Authors:  Oliver A Kent; Dustin B Ritchie; Andrew M Macmillan
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  The architecture of pre-mRNAs affects mechanisms of splice-site pairing.

Authors:  Kristi L Fox-Walsh; Yimeng Dou; Bianca J Lam; She-Pin Hung; Pierre F Baldi; Klemens J Hertel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

5.  Functional spliceosomal A complexes can be assembled in vitro in the absence of a penta-snRNP.

Authors:  Nastaran Behzadnia; Klaus Hartmuth; Cindy L Will; Reinhard Lührmann
Journal:  RNA       Date:  2006-07-31       Impact factor: 4.942

6.  Genomic splice-site analysis reveals frequent alternative splicing close to the dominant splice site.

Authors:  Yimeng Dou; Kristi L Fox-Walsh; Pierre F Baldi; Klemens J Hertel
Journal:  RNA       Date:  2006-10-19       Impact factor: 4.942

7.  Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes.

Authors:  Nastaran Behzadnia; Monika M Golas; Klaus Hartmuth; Bjoern Sander; Berthold Kastner; Jochen Deckert; Prakash Dube; Cindy L Will; Henning Urlaub; Holger Stark; Reinhard Lührmann
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

8.  Multiple U2AF65 binding sites within SF3b155: thermodynamic and spectroscopic characterization of protein-protein interactions among pre-mRNA splicing factors.

Authors:  Karen R Thickman; Matthew C Swenson; Joseph M Kabogo; Zygmunt Gryczynski; Clara L Kielkopf
Journal:  J Mol Biol       Date:  2005-12-07       Impact factor: 5.469

9.  Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex.

Authors:  Shalini Sharma; Arnold M Falick; Douglas L Black
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

Review 10.  Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.

Authors:  Mo Chen; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-23       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.